| SciPort RLP

Publikationen

Raker, Verena K.; Ook, Kim Y.; Haub, Jessica et al.

Myeloid cell populations and fibrogenic parameters in bleomycin- and HOCl-induced fibrosis

EXPERIMENTAL DERMATOLOGY. Bd. 25. H. 11. 2016 S. 887-894

Tuettenberg, Andrea; Steinbrink, Kerstin; Schuppan, Detlef

Myeloid cells as orchestrators of the tumor microenvironment: novel targets for nanoparticular cancer therapy

NANOMEDICINE. Bd. 11. H. 20. 2016 S. 2735-2751

Bittner, Stefan; Wiendl, Heinz

Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications

NEUROTHERAPEUTICS. Bd. 13. H. 1. 2016 S. 4-19

Hahn, Matthias; Macht, Anna; Waisman, Ari et al.

NF-kappa B-inducing kinase is essential for B-cell maintenance in mice

EUROPEAN JOURNAL OF IMMUNOLOGY. Bd. 46. H. 3. 2016 S. 732-741

Kerstan, A.; Alrefai, H.; Muhammad, K. et al.

NFATc1 promotes imiquimod-induced skin inflammation by negatively controlling IL-10 production in B cells

EXPERIMENTAL DERMATOLOGY. Bd. 25. H. 3. 2016 S. E26-E26

Busch, Rhoda; Murti, Krisna; Liu, Jiming et al.

NFATc1 releases BCL6-dependent repression of CCR2 agonist expression in peritoneal macrophages from Saccharomyces cerevisiae infected mice

EUROPEAN JOURNAL OF IMMUNOLOGY. Bd. 46. H. 3. 2016 S. 634-646

Muhammad, K.; Alrefai, H.; Rudolf, R. et al.

NFATc1 supports imiquimod- induced skin inflammation by suppressing regulatory B cells

EUROPEAN JOURNAL OF IMMUNOLOGY. Bd. 46. 2016 S. 1136-1136

Alrefai, Hani; Muhammad, Khalid; Rudolf, Ronald et al.

NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells

NATURE COMMUNICATIONS. Bd. 7. 2016

Alrefai, Hani; Muhammad, Khalid; Rudolf, Ronald et al.

NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells (vol 7, 11724, 2016)

Nature Communications. Bd. 7. 2016

Stankovic, Nevenka Dudvarski; Hoppmann, Nicola; Teodorczyk, Marcin et al.

No role of IFITM3 in brain tumor formation in vivo

ONCOTARGET. Bd. 7. H. 52. 2016 S. 86388-86405